Dosepharmacy

Ralista 60, containing raloxifene hydrochloride, is a medication primarily used to treat and prevent osteoporosis in postmenopausal women. Additionally, it has proven benefits in reducing the risk of invasive breast cancer in postmenopausal women at high risk or with osteoporosis. Ralista 60 functions as a selective estrogen receptor modulator (SERM), which means it mimics estrogen's beneficial effects on bones while blocking its potentially harmful effects on breast tissue.